Leading Cancer Hospitals in India

Yes. We ensure that your case is clinically evaluated before you book a flight. Once you submit your current biopsy reports, PET-CT scans, and medical history through IndiCure, our team routes them to the senior oncology specialists at your shortlisted hospitals.

The doctors will provide a pre-travel medical opinion, confirming your eligibility for the proposed treatment, outlining potential surgical or non-surgical paths, and setting realistic expectations.

IndiCure has meticulously vetted and selected above listed hospitals, bypassing general clinics to connect international patients with specific, world-class clinical infrastructure:

• Pioneering Precision Technology: We partner with India's one and only private advanced Proton Beam Therapy hospital Apollo Proton Cancer Centre (Chennai). For high-end robotic surgery and precise radiosurgery, we feature Medanta - The Medicity (Delhi NCR), Nanavati Max Super Speciality Hospital (Mumbai), and Fortis Memorial Research Institute (FMRI, Delhi NCR), a global leader in pediatric oncology and bone marrow transplants.
• Specialized & Focused Oncology: Our network includes Apollo Athenaa Women's Cancer Centre (New Delhi), Asia's first dedicated hub for female breast and gynecologic cancers. For highly targeted radiation and personalized immunotherapy protocols, we select HCG Hospitals (Colaba & Borivali, Mumbai) and Artemis Hospital (Delhi NCR).
• Massive, Multi-Specialty Ecosystems: To ensure zero patient movement, Amrita Hospital (Faridabad) offers a vast, advanced clinical infrastructure, while Apollo Hospitals (Navi Mumbai) and Gleneagles Hospital (Parel, Mumbai) provide dedicated international patient wings, on-site PET-CT imaging, and immediate critical care (ICU) backups under a single roof.

Clinical quality and technology at our selected cancer hospitals in India match Western standards, but with the distinct advantages of zero waiting times and lower costs.

• Identical Technology and Outcomes: IndiCure's selected hospital utilizes the same as USFDA-approved technologies such as the Proton Beam Therapy and robotic surgery.
• No Waiting Lists: While Western healthcare systems often have weeks of delays for specialized oncology appointments, IndiCure fast-tracks your diagnostics and begins your targeted treatment within 3 to 7 days of arrival at your selected hospital
• Globally Trained, High-Volume Surgeons: The senior oncologists across our selected hospitals hold fellowships from premier US and UK institutions. Because of India's population density, these specialists perform a much higher volume of complex surgeries compared to their Western peers, resulting in highly refined clinical expertise.

IndiCure exclusively partners with fully integrated, multi-specialty tertiary care hospitals, completely avoiding standalone day-care clinics for primary cancer treatments.

Every hospital in our collection features a dedicated 24/7 Oncology Emergency Unit, an advanced Surgical Intensive Care Unit (SICU), and on-site blood banks equipped for component therapy. Because these are massive, comprehensive medical ecosystems, if a patient experiences an unexpected complication, specialists from other departments—such as Cardiology, Nephrology, or Pulmonology—are available in-house to intervene immediately, ensuring absolute clinical backup at all times.

Continuity of care remains an important part of cancer recovery. Before departure, patients receive a comprehensive medical dossier containing surgical summaries, chemotherapy protocols, radiation treatment details, and follow-up recommendations. Our hospitals also offer teleconsultation services that allow patients to review recovery progress, scan results, and ongoing concerns with their treating oncologist. To support local follow-up care, medical records and imaging can be securely shared with your healthcare providers in your home country.

All diagnostic equipment, robotic suites, and radiation platforms are reviewed against active national (NABH) and international (JCI) accreditation standards. Using IndiCure's Hospital Selection Criteria, our quality team annually evaluates hospitals across multiple parameters, including infrastructure, patient safety, and clinical capabilities. Additional specialty-specific factors and treatment-related facilities are also assessed depending on the medical condition and area of care.

All oncology hospitals selected by IndiCure follow a multidisciplinary approach to cancer care through site-specific Tumor Boards. Because cancer is complex and often requires multiple treatment modalities, these boards bring together medical, surgical, and radiation oncologists, pathologists, and other specialists to review each patient's diagnostic findings and treatment options. This collaborative process helps coordinate surgery, systemic therapies such as chemotherapy or CAR T-cell therapy, perfectly with localized protocols (like robotic surgery or stereotactic radiation), drastically improving the likelihood of delivering the right treatment on the very first attempt.

Standard photon radiation travels entirely through the human body, delivering radiation doses to healthy tissue both before and after hitting the tumor site. Conversely, Proton Therapy utilizes heavy charged particles that can be calibrated to release their peak energy (the Bragg Peak) precisely within the customized boundaries of the tumor and then stop completely. Because there is zero exit-dose radiation, it is uniquely curated to protect critical, high-risk organs specially for pediatric, skull-base, and cardiac malignancies.

Chimeric Antigen Receptor CAR T-cell is a revolutionary immunotherapy for relapsed or refractory blood cancers—especially large B-cell lymphomas, B-ALL, and multiple myeloma—after standard treatments fail.

It collects a patient's T-cells, engineers them to target cancer proteins, and re-infuses them to kill malignant cells.

Eligible candidates usually have measurable disease, ECOG 0-2, adequate organ function, no uncontrolled infection, and caregiver support near a certified center. Risks include CRS and neurotoxicity, requiring ICU-ready teams and strict isolation facilities. Not ideal for severe organ failure, uncontrolled infection, or very poor performance status. Leading Indian hubs like FMRI, Medanta, and Amrita offer such infrastructure.

When choosing a hospital for oncology care, the specific radiation technology available directly impacts your treatment timeline, comfort, and recovery. Leading hospitals utilize two distinct types of advanced radiation systems, choosing the best fit based on your specific tumor profile:

• Standard Linear Accelerator (Linac): Advanced hospitals use platforms like the Varian TrueBeam STx or Elekta Versa HD. These are the workhorses of radiation oncology, designed to treat larger tumor fields or regional areas (such as the whole breast, pelvic area, or lymph node chains) with extreme efficiency.
• CyberKnife Robotic Radiosurgery: This represents the pinnacle of non-invasive robotic oncology. Mounted on a highly articulating robotic arm, CyberKnife delivers hundreds of sub-millimeter, concentrated beams from thousands of angles. Because it tracks tumor movement in real time, it is the premier choice for ablating small, complex, or moving tumors (like those in the brain, spine, lung, or liver) while completely sparing adjacent healthy tissue.